Short Interest in Esperion Therapeutics, Inc. (NASDAQ:ESPR) Decreases By 6.6%
Esperion Therapeutics, Inc. (NASDAQ:ESPR – Get Free Report) saw a large decline in short interest during the month of November. As of November 15th, there was short interest totalling 31,250,000 shares, a decline of 6.6% from the October 31st total of 33,460,000 shares. Based on an average daily volume of 3,820,000 shares, the days-to-cover ratio […]
More Stories
Reviewing Evertz Technologies (OTCMKTS:EVTZF) and u-blox (OTCMKTS:UBLXF)
Evertz Technologies (OTCMKTS:EVTZF – Get Free Report) and u-blox (OTCMKTS:UBLXF – Get Free Report) are both computer and technology companies,...
Critical Review: Buzzi (OTCMKTS:BZZUF) versus CRH (NYSE:CRH)
CRH (NYSE:CRH – Get Free Report) and Buzzi (OTCMKTS:BZZUF – Get Free Report) are both construction companies, but which is...
General Enterprise Ventures (GEVI) & Its Peers Critical Analysis
Earnings and Valuation This table compares General Enterprise Ventures and its peers top-line revenue, earnings per share and valuation. Gross...
Tempus AI (NASDAQ:TEM) versus Tremor International (NASDAQ:TRMR) Critical Review
Tremor International (NASDAQ:TRMR – Get Free Report) and Tempus AI (NASDAQ:TEM – Get Free Report) are both business services companies,...
Financial Analysis: Harleysville Financial (OTCMKTS:HARL) and Landmark Bancorp (NASDAQ:LARK)
Insider and Institutional Ownership 25.7% of Landmark Bancorp shares are held by institutional investors. Comparatively, 1.2% of Harleysville Financial shares...
Reviewing TaskUs (NASDAQ:TASK) & Sterling Check (NASDAQ:STER)
Sterling Check (NASDAQ:STER – Get Free Report) and TaskUs (NASDAQ:TASK – Get Free Report) are both small-cap business services companies,...